Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

154 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Use of Systemic Therapies for Treatment of Psoriasis in Patients with a History of Treated Solid Tumours: Inference-Based Guidance from a Multidisciplinary Expert Panel.
Papp KA, Melosky B, Sehdev S, Hotte SJ, Beecker JR, Kirchhof MG, Turchin I, Dutz JP, Gooderham MJ, Gniadecki R, Hong CH, Lambert J, Lynde CW, Prajapati VH, Vender RB. Papp KA, et al. Among authors: hotte sj. Dermatol Ther (Heidelb). 2023 Apr;13(4):867-889. doi: 10.1007/s13555-023-00905-3. Epub 2023 Mar 16. Dermatol Ther (Heidelb). 2023. PMID: 36929121 Free PMC article.
Controversial issues in the management of patients with advanced prostate cancer: Results from a Canadian consensus forum.
Saad F, Canil C, Finelli A, Hotte SJ, Malone S, Shayegan B, So AI, Aaron L, Basappa NS, Conter HJ, Danielson B, Gotto G, Hamilton RJ, Izard JP, Kapoor A, Kolinsky M, Lalani AA, Lattouf JB, Morash C, Morgan SC, Niazi T, Noonan KL, Ong M, Rendon RA, Sehdev S, Hew H, Park-Wyllie L, Chi KN. Saad F, et al. Among authors: hotte sj. Can Urol Assoc J. 2020 Apr;14(4):E137-E149. doi: 10.5489/cuaj.6082. Epub 2019 Nov 5. Can Urol Assoc J. 2020. PMID: 31702544 Free PMC article. Review.
Evaluation of second-line and subsequent targeted therapies in metastatic renal cell cancer (mRCC) patients treated with first-line cediranib.
Richter S, Seah JA, Pond GR, Gan HK, Mackenzie MJ, Hotte SJ, Mukherjee SD, Murray N, Kollmannsberger C, Heng D, Haider MA, Halford R, Ivy SP, Moore MJ, Sridhar SS. Richter S, et al. Among authors: hotte sj. Can Urol Assoc J. 2014 Nov;8(11-12):398-402. doi: 10.5489/cuaj.2426. Can Urol Assoc J. 2014. PMID: 25553152 Free PMC article.
Real-world use of systemic therapies in men with metastatic castration resistant prostate cancer (mCRPC) in Canada.
Shayegan B, Wallis CJD, Malone S, Cagiannos I, Hamilton RJ, Ferrario C, Gotto GT, Basappa NS, Morgan SC, Fernandes R, Morash C, Niazi T, Noonan KL, Rendon R, Osborne B, Park-Wyllie L, Chan KFY, Hotte SJ, Saad F. Shayegan B, et al. Among authors: hotte sj. Urol Oncol. 2022 May;40(5):192.e1-192.e9. doi: 10.1016/j.urolonc.2022.01.009. Epub 2022 Feb 23. Urol Oncol. 2022. PMID: 35216890 Free article.
Bone Health and Bone-targeted Therapies for Prostate Cancer: a Programme in Evidence-based Care - Cancer Care Ontario Clinical Practice Guideline.
Alibhai SMH, Zukotynski K, Walker-Dilks C, Emmenegger U, Finelli A, Morgan SC, Hotte SJ, Winquist E; Cancer Care Ontario Genitourinary Cancer Disease Site Group. Alibhai SMH, et al. Among authors: hotte sj. Clin Oncol (R Coll Radiol). 2017 Jun;29(6):348-355. doi: 10.1016/j.clon.2017.01.007. Epub 2017 Feb 4. Clin Oncol (R Coll Radiol). 2017. PMID: 28169118 Review.
Kidney Cancer Research Network of Canada consensus statement on the role of adjuvant therapy after nephrectomy for high-risk, non-metastatic renal cell carcinoma: A comprehensive analysis of the literature and meta-analysis of randomized controlled trials.
Karakiewicz PI, Zaffuto E, Kapoor A, Basappa NS, Bjarnason GA, Blais N, Breau RH, Canil C, Drachenberg D, Hotte SJ, Jeldres C, Jewett MAS, Kassouf W, Kollmannsberger C, Lavallée LT, Maloni R, Patenaude F, Pouliot F, Reaume MN, Sabbagh R, Shayegan B, So A, Soulières D, Tanguay S, Wood L, Bandini M. Karakiewicz PI, et al. Among authors: hotte sj. Can Urol Assoc J. 2018 Jun;12(6):173-180. doi: 10.5489/cuaj.5187. Can Urol Assoc J. 2018. PMID: 29877179 Free PMC article.
Prioritizing systemic therapies for genitourinary malignancies: Canadian recommendations during the COVID-19 pandemic.
Lalani AA, Chi KN, Heng DYC, Kollmannsberger CK, Sridhar SS, Blais N, Canil C, Czaykowski P, Hotte SJ, Iqbal N, Soulières D, Bossé D, Alimohamed NS, Basappa NS, Mukherjee SD, Winquist E, Wood LA, North SA. Lalani AA, et al. Among authors: hotte sj. Can Urol Assoc J. 2020 May;14(5):E154-E158. doi: 10.5489/cuaj.6595. Epub 2020 Apr 5. Can Urol Assoc J. 2020. PMID: 32267828 Free PMC article. No abstract available.
154 results